Details for New Drug Application (NDA): 207753
✉ Email this page to a colleague
The generic ingredient in IBUPROFEN is ibuprofen sodium. There are sixty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ibuprofen sodium profile page.
Summary for 207753
Tradename: | IBUPROFEN |
Applicant: | Aurobindo Pharma Ltd |
Ingredient: | ibuprofen |
Patents: | 0 |
Pharmacology for NDA: 207753
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 207753
Suppliers and Packaging for NDA: 207753
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
IBUPROFEN | ibuprofen | CAPSULE;ORAL | 207753 | ANDA | RITE AID CORPORATION | 11822-4258 | 11822-4258-1 | 1 BOTTLE in 1 CARTON (11822-4258-1) / 20 CAPSULE in 1 BOTTLE |
IBUPROFEN | ibuprofen | CAPSULE;ORAL | 207753 | ANDA | RITE AID CORPORATION | 11822-4258 | 11822-4258-2 | 1 BOTTLE in 1 CARTON (11822-4258-2) / 40 CAPSULE in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | CAPSULE;ORAL | Strength | EQ 200MG FREE ACID AND POTASSIUM SALT | ||||
Approval Date: | Jun 29, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription